StockData
Repligen Corp logo

Repligen Corp (RGEN) stock

RGENNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 7/30133% above fair value
$162.18−0.60 (-0.37%)

Close on Nov 17, 2026Market cap $10.37BP/E –Yield –

Repligen EPS

Diluted earnings per share is net income divided by the share count including options and convertible securities.

Repligen's EPS for the twelve months ending Sep 30, 2021 was $2.10, up 156.1% year over year. For fiscal 2025 it was $0.86. Over ten years it grew 11.9% a year on average. The highest annual figure on record is $3.24 in fiscal 2022.

Annual eps

PeriodPeriod endValueChange
FY2025Dec 31, 2025$0.86–
FY2024Dec 31, 2024-$0.46-173.0%
FY2023Dec 31, 2023$0.63-80.6%
FY2022Dec 31, 2022$3.24+44.6%
FY2021Dec 31, 2021$2.24+101.8%
FY2020Dec 31, 2020$1.11+152.3%
FY2019Dec 31, 2019$0.44+18.9%
FY2018Dec 31, 2018$0.37-48.6%
FY2017Dec 31, 2017$0.72+111.8%
FY2016Dec 31, 2016$0.34+21.4%
FY2015Dec 31, 2015$0.28+12.0%
FY2014Dec 31, 2014$0.25-50.0%
FY2013Dec 31, 2013$0.50–
FY2011Mar 31, 2011$0.00–
FY2010Mar 31, 2010-$0.13–

Quarterly eps

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026-$0.68-361.5%
Q2 FY2026Jun 30, 2026$0.09-10.0%
Q1 FY2026Mar 31, 2026$0.15–
Q3 FY2025Sep 30, 2025$0.26+160.0%
Q2 FY2025Jun 30, 2025$0.26+333.3%
Q1 FY2025Mar 31, 2025$0.10-66.7%
Q3 FY2024Sep 30, 2024-$0.01-102.9%
Q2 FY2024Jun 30, 2024$0.10-63.0%
Q1 FY2024Mar 31, 2024$0.06-91.5%
Q3 FY2023Sep 30, 2023$0.30-65.9%
Q2 FY2023Jun 30, 2023$0.35-56.8%
Q1 FY2023Mar 31, 2023$0.27-53.4%
Q3 FY2022Sep 30, 2022$0.71+10.9%
Q2 FY2022Jun 30, 2022$0.88+69.2%
Q1 FY2022Mar 31, 2022$0.81+125.0%
Q3 FY2021Sep 30, 2021$0.58+114.8%
Q2 FY2021Jun 30, 2021$0.64+113.3%
Q1 FY2021Mar 31, 2021$0.52+188.9%
Q4 FY2020Dec 31, 2020$0.36+414.3%
Q3 FY2020Sep 30, 2020$0.27+800.0%
Q2 FY2020Jun 30, 2020$0.30+76.5%
Q1 FY2020Mar 31, 2020$0.18+5.9%
Q4 FY2019Dec 31, 2019$0.07-41.7%
Q3 FY2019Sep 30, 2019$0.03-70.0%
Q2 FY2019Jun 30, 2019$0.17+183.3%
Q1 FY2019Mar 31, 2019$0.17+112.5%
Q4 FY2018Dec 31, 2018$0.12-55.6%
Q3 FY2018Sep 30, 2018$0.10-9.1%
Q2 FY2018Jun 30, 2018$0.06-75.0%
Q1 FY2018Mar 31, 2018$0.08-11.1%
Q4 FY2017Dec 31, 2017$0.27+80.0%
Q3 FY2017Sep 30, 2017$0.11–
Q2 FY2017Jun 30, 2017$0.24–
Q1 FY2017Mar 31, 2017$0.09–
Q4 FY2016Dec 31, 2016$0.15–

More Repligen figures

See a number that looks wrong?